Waters CEO Hints at New Platform, 'Exciting' Year for Mass Spec Business in 2010 | GenomeWeb

This story originally ran on Jan. 26.

The CEO of Waters forecast an "exciting year" for mass spectrometry in the company this week in the midst of reporting a 3 percent climb in revenues for the fourth quarter of 2009.

For the three months ended Dec. 31, 2009, the company reported receipts of $428.8 million, up from $418.3 million a year ago. Profits rose to $104.1 million, or $1.08 per share, from $99.4 million, or $1.01 per share, from the year-ago period.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.